Accuray Incorporated (ARAY): Price and Financial Metrics
ARAY Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for ARAY is 4.85 -- better than 92.21% of US stocks.
- ARAY's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 83.84% of US stocks.
- Over the past twelve months, ARAY has reported earnings growth of 643.84%, putting it ahead of 97.35% of US stocks in our set.
- If you're looking for stocks that are quantitatively similar to Accuray Inc, a group of peers worth examining would be PCTI, CSGS, ATEN, ERII, and KN.
- Visit ARAY's SEC page to see the company's official filings. To visit the company's web site, go to www.accuray.com.
ARAY Stock Price Chart Interactive Chart >
ARAY Price/Volume Stats
| Current price | $5.26 | 52-week high | $6.01 |
| Prev. close | $5.11 | 52-week low | $1.75 |
| Day low | $5.16 | Volume | 657,910 |
| Day high | $5.41 | Avg. volume | 855,725 |
| 50-day MA | $5.21 | Dividend yield | N/A |
| 200-day MA | $3.84 | Market Cap | 488.64M |
Accuray Incorporated (ARAY) Company Bio
Accuray Inc. designs, develops, and sells radio-surgery and radiation therapy systems for the treatment of tumors in the body. It offers the CyberKnife System, a robotic stereotactic radio-surgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. The company was founded in 1990 and is based in Sunnyvale, California.
Most Popular Stories View All
View All Top StoriesGet Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Latest ARAY News From Around the Web
Below are the latest news stories about Accuray Inc that investors may wish to consider to help them evaluate ARAY as an investment opportunity.
Accuray to Report Third Quarter Fiscal 2021 Financial Results on April 27, 2021Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2021, ended March 31, 2021, after the market close on Tuesday April 27, 2021. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m. ET on the same day. |
The Zacks Analyst Blog Highlights: Smith & Nephew, Intuitive Surgical, Stryker Corp, Accuray and MedtronicThe Zacks Analyst Blog Highlights: Smith & Nephew, Intuitive Surgical, Stryker Corp, Accuray and Medtronic |
Coronavirus Ups the Game for Robotic Surgery: 3 Stocks on RadarLet's keep a watch on the potentially strong three MedTech stocks, namely SYK, ARAY and MDT with respect to robotic-assisted surgery that showed promises during the pandemic. |
Bone Cancer Market With Key Players like Novartis AG, Pfizer, Bayer AG, Takeda Pharmaceutical Company, Johnson and Johnson, Eli Lilly and Company, BD, Accuray Incorporated, Bristol-Myers Squibb Company, Merck & Co. Inc.Bone cancer is diagnosed when there is abnormal cell growth in the bone and it tends to destroy bone tissue. It is a rare type of cancer in adults however, it may spread to lungs. The beast treatment option for |
Accuray to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceSUNNYVALE, Calif., Feb. 5, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced its participation in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference. The management team is scheduled to participate in a Fireside Chat on Thursday,… |
ARAY Price Returns
| 1-mo | 6.05% |
| 3-mo | 2.94% |
| 6-mo | 69.68% |
| 1-year | 198.86% |
| 3-year | 4.16% |
| 5-year | -14.19% |
| YTD | 26.14% |
| 2020 | 47.87% |
| 2019 | -17.30% |
| 2018 | -20.70% |
| 2017 | -6.52% |
| 2016 | -31.85% |
Continue Researching ARAY
Want to see what other sources are saying about Accuray Inc's financials and stock price? Try the links below:Accuray Inc (ARAY) Stock Price | Nasdaq
Accuray Inc (ARAY) Stock Quote, History and News - Yahoo Finance
Accuray Inc (ARAY) Stock Price and Basic Information | MarketWatch
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Loading social stream, please wait...